Resolutions from the Annual General Meeting of Novo Nordisk A/S - Seite 2

The Board of Directors, including its committees, are now composed as follows:

• Göran Ando (chairman of the Board, of the Nomination Committee and of the Research & Development Committee)
• Jeppe Christiansen (vice chairman of the Board and chairman of the Remuneration Committee)

Brian Daniels (member of the Research & Development Committee)

Sylvie Grégoire (member of the Audit Committee and the Research & Development Committee)

Liz Hewitt (chairman of the Audit Committee and member of the Nomination Committee)

Liselotte Hyveled (employee representative and member of the Research & Development Committee)

Kasim Kutay (member of the Nomination Committee and the Remuneration Committee)

Anne Marie Kverneland (employee representative and member of the Remuneration Committee)

Helge Lund (member of the Audit Committee and the Nomination Committee)

Søren Thuesen Pedersen (employee representative and member of the Nomination Committee)

Stig Strøbæk (employee representative and member of the Audit Committee)

Mary Szela (member of the Remuneration Committee)

Further information

Media:
Katrine Sperling	[phone]	[e-mail]
Ken Inchausti (US)	[phone]	[e-mail]
Investors:
Peter Hugreffe Ankersen	[phone]	[e-mail]
Hanna Ögren	[phone]	[e-mail]
Anders Mikkelsen	[phone]	[e-mail]
Kasper Veje (US)	[phone]	[e-mail]